Effects of once-weekly semaglutide 2.4 mg on C-reactive protein in adults with overweight or obesity (STEP 1, 2, and 3): exploratory analyses of three randomised, double-blind, placebo-controlled, phase 3 trials
Accessibility: If you are vision-impaired or have some other impairment covered by the Americans with Disabilities Act or a similar law, and you wish to discuss potential accommodations related to using this website, please contact our Accessibility Manager at (512) 572-6634.
Dive into a world where skin transformation is not just a dream but a tangible reality
Cardiovascular Protection Early studies suggest possible benefits in vascular and cardiac tissue research
As your dose is gradually increased, the appetite-suppressing effects become stronger, helping you feel fuller more consistently over time
If you have type 1 diabetes or want to lose weight, talk with your doctor